Category: Ejected Players

Ejected Players – Ejecting.net

Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA

WILMINGTON, Del.–(BUSINESS WIRE[1])–New data from a large, contemporary US hospitalized heart failure (HF) registry confirms that four out of five (81.1%) patients with NYHA class II-IV HF with reduced ejection fraction (HFrEF), with and without type 2 diabetes (T2D), could be considered as eligible candidates for sodium glucose co-transporter 2 (SGLT2) inhibitor FARXIGA® (dapagliflozin). The analysis, presented today at the...

READ MORE Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA

Aircraft Ejection Seats Market Study, Growth Factor, CAGR Fluctuation Probability

Pune, Maharashtra, India, October 27 2020 (Wiredrelease) MarketResearch.Biz :The recently published market study byMarketResearch.Bizhighlights the current and future trends that are expected to influence the dynamics of the Aircraft Ejection Seats Market[1] in the upcoming years. The report introspects the supply chain, cost structure, and recent developments pertaining to the Aircraft Ejection Seats market in the report. Further, the micro...

READ MORE Aircraft Ejection Seats Market Study, Growth Factor, CAGR Fluctuation Probability

Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction

DANVERS, Mass.–(BUSINESS WIRE[1])–The Restore EF Study demonstrates the use of contemporary best practices, including attempting a more complete revascularization with Impella[2]-supported high-risk PCI, is associated with significant improvement of left ventricular ejection fraction (LVEF), heart failure symptoms, and anginal symptoms at follow up. The interim analysis was presented today by Mitul Patel, MD, an interventional cardiologist at UC San Diego...

READ MORE Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction

US FDA approve EchoMD AutoEF software for calculating LVEF

Visual by Bay Labs Bay Labs has received US FDA 510(k) clearance for its EchoMD AutoEF software product for the fully automated clip selection and calculation of left ventricular ejection fraction. The EchoMD AutoEF algorithms are designed to eliminate the need to manually select views, choose the best clips, and manipulate them for quantification, an often time-consuming and highly variable...

READ MORE US FDA approve EchoMD AutoEF software for calculating LVEF